1. Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody. (December 2015) Authors: Hopkins, Paul N.; Defesche, Joep; Fouchier, Sigrid W.; Bruckert, Eric; Luc, Gérald; Cariou, Bertrand; Sjouke, Barbara; Leren, Trond P.; Harada-Shiba, Mariko; Mabuchi, Hiroshi; Rabès, Jean-Pierre; Carrié, Alain; van Heyningen, Charles; Carreau, Valérie; Farnier, Michel; Teoh, Yee P.; Bourbon, Mafa... Journal: Circulation Issue: Volume 8:Number 6(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates. (31st May 2018) Authors: Pascal, Kristen E; Dudgeon, Drew; Trefry, John C; Anantpadma, Manu; Sakurai, Yasuteru; Murin, Charles D; Turner, Hannah L; Fairhurst, Jeanette; Torres, Marcela; Rafique, Ashique; Yan, Ying; Badithe, Ashok; Yu, Kevin; Potocky, Terra; Bixler, Sandra L; Chance, Taylor B; Pratt, William D; Rossi, Fra... Journal: Journal of infectious diseases Issue: Volume 218(2018)Supplement 5 Page Start: S612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation. Issue 5 (3rd January 2020) Authors: Le Floc'h, Audrey; Allinne, Jeanne; Nagashima, Kirsten; Scott, George; Birchard, Dylan; Asrat, Seblewongel; Bai, Yu; Lim, Wei Keat; Martin, Joel; Huang, Tammy; Potocky, Terra B.; Kim, Jee H.; Rafique, Ashique; Papadopoulos, Nicholas J.; Stahl, Neil; Yancopoulos, George D.; Murphy, Andrew J.; Slee... Journal: Allergy Issue: Volume 75:Issue 5(2020) Page Start: 1188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Issue 10039 (2nd July 2016) Authors: Wenzel, Sally; Castro, Mario; Corren, Jonathan; Maspero, Jorge; Wang, Lin; Zhang, Bingzhi; Pirozzi, Gianluca; Sutherland, E Rand; Evans, Robert R; Joish, Vijay N; Eckert, Laurent; Graham, Neil M H; Stahl, Neil; Yancopoulos, George D; Louis-Tisserand, Mariana; Teper, Ariel Journal: Lancet Issue: Volume 388:Issue 10039(2016) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial. Issue 10 (October 2022) Authors: Herman, Gary A; O'Brien, Meagan P; Forleo-Neto, Eduardo; Sarkar, Neena; Isa, Flonza; Hou, Peijie; Chan, Kuo-Chen; Bar, Katharine J; Barnabas, Ruanne V; Barouch, Dan H; Cohen, Myron S; Hurt, Christopher B; Burwen, Dale R; Marovich, Mary A; Musser, Bret J; Davis, John D; Turner, Kenneth C; Mahmood,... Journal: Lancet infectious diseases Issue: Volume 22:Issue 10(2022) Page Start: 1444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Issue 10013 (2nd January 2016) Authors: Thaçi, Diamant; Simpson, Eric L; Beck, Lisa A; Bieber, Thomas; Blauvelt, Andrew; Papp, Kim; Soong, Weily; Worm, Margitta; Szepietowski, Jacek C; Sofen, Howard; Kawashima, Makoto; Wu, Richard; Weinstein, Steven P; Graham, Neil M H; Pirozzi, Gianluca; Teper, Ariel; Sutherland, E Rand; Mastey, Vera;... Journal: Lancet Issue: Volume 387:Issue 10013(2016) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Issue 10209 (2nd November 2019) Authors: Bachert, Claus; Han, Joseph K; Desrosiers, Martin; Hellings, Peter W; Amin, Nikhil; Lee, Stella E; Mullol, Joaquim; Greos, Leon S; Bosso, John V; Laidlaw, Tanya M; Cervin, Anders U; Maspero, Jorge F; Hopkins, Claire; Olze, Heidi; Canonica, G Walter; Paggiaro, Pierluigi; Cho, Seong H; Fokkens, Wyt... Journal: Lancet Issue: Volume 394:Issue 10209(2019) Page Start: 1638 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II/III randomised clinical trial. Issue 4 (16th November 2020) Authors: Dakin, Paula; Kivitz, Alan J; Gimbel, Joseph S; Skrepnik, Nebojsa; DiMartino, Stephen J; Emeremni, Chetachi A; Gao, Haitao; Stahl, Neil; Weinreich, David M; Yancopoulos, George D; Geba, Gregory P Journal: Annals of the rheumatic diseases Issue: Volume 80:Issue 4(2021) Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome Coronavirus. (28th January 2021) Authors: Sivapalasingam, Sumathi; Saviolakis, George A; Kulcsar, Kirsten; Nakamura, Aya; Conrad, Thomas; Hassanein, Mohamed; Sumner, Giane; Elango, Chinnasamy; Kamal, Mohamed A; Eng, Simon; Kyratsous, Christos A; Musser, Bret J; Frieman, Matthew; Kantrowitz, Joel; Weinreich, David M; Yancopoulos, George; ... Journal: Journal of infectious diseases Issue: Volume 225:Number 10(2022) Page Start: 1765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. LB4. Casirivimab and Imdevimab for Treatment of Hospitalized Patients With COVID-19 Receiving Low Flow or No Supplemental Oxygen. (4th December 2021) Authors: Mylonakis, Eleftherios; Somersan-Karakaya, Selin; Sivapalasingam, Sumathi; Ali, Shazia; Sun, Yiping; Bhore, Rafia; Mei, Jingning; Miller, Jutta; Cupelli, Lisa; Hooper, Andrea T; Hamilton, Jennifer D; Pan, Cynthia; Pham, Viet; Zhao, Yuming; Hosain, Romana; Mahmood, Adnan; Davis, John D; Turner, Ke... Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S809 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗